瀏覽 的方式: 作者 鄧哲明(Che-Ming Teng)
顯示 1 到 10 筆資料,總共 10 筆
出版年 | 標題 | 作者 | 系所 |
2012 | "AR42, QS-ZYX-1-61,及erolotinib和MPT0E028併用之抗腫瘤藥效與機制探討" Effects and action mechanisms of AR42, QS-ZYX-1-61, and combination of erlotinib-MPT0E028 in cancer cells | Mei-Chuan Chen; 陳美全 | 藥理學研究所 |
2008 | Baicalein, KS-5與YD-3對血管平滑肌及內皮細胞之生長調控作用及在血管再阻塞與血管新生之藥效評估 Effects of Baicalein, KS-5 and YD-3 on Growth Regulation in Vascular Smooth Muscle Cells and Endothelial Cells, and Therapeutic Evaluation in Models of Restenosis and Angiogenesis | Chieh-Yu Peng; 彭婕妤 | 藥理學研究所 |
2012 | ERMAs與protopine在癌細胞中引起細胞凋亡之機轉探討以及sorafenib與MPT0E028併用之抗癌效果 Action mechanisms of ERMAs- and protopine-induced apoptosis and the antitumor activity of sorafenib-MPT0E028 combination in human cancer cells. | Chun-Han Chen; 陳俊翰 | 藥理學研究所 |
2005 | Evodiamine, Genistein及YC-1對人類乳癌細胞之作用機轉的探討 The Anti-Cancer Mechanism of Evodiamine, Genistein and YC-1 in Human Breast Cancer Cell Lines | Cho-Hwa Liao; 廖灼華 | 藥理學研究所 |
2010 | Moscatilin 之衍生物 MT-6 在人類卵巢癌細胞引起細胞凋亡之機轉探討 The apoptotic mechanisms of MT-6, a derivative of moscatilin, in human ovarian cancer cells | Yi-Chiu Kuo; 郭憶萩 | 藥理學研究所 |
2013 | Protease-activated receptors (PARs) 調控癌症進程之機轉探討 The mechanism of cancer progression regulated by protease-activated receptors (PARs) | Li-Hsun Chang; 張儷薰 | 藥理學研究所 |
2006 | 探討oxLDL在人類臍帶靜脈內皮細胞ECV304經由調控PI3K/Akt 和Ras/ERK途徑來活化 hypoxia-inducible factor-1α的作用機轉 OxLDL Activates Hypoxia-Inducible Factor-1α in Human Umbilical Vein Endothelial Cell Line ECV304 through PI3K/Akt and Ras/ERK Pathways | Li-Lin Huang; 黃麗霖 | 藥理學研究所 |
2006 | 探討人類纖維母細胞中PKC δ在bFGF誘導urokinase-type plasminogen activator 生成中之重要角色 Protein kinase C δ plays a critical role in bFGF-induced urokinase-type plasminogen activator production in human fibroblasts | Chih-Yu Liao; 廖志裕 | 藥理學研究所 |
2014 | 探討新合成arylamide衍生物MPT0B640誘導細胞凋亡與合併etoposide呈現協同作用於人類非小細胞肺癌之體外及體內的作用機轉 MPT0B640, a novel synthetic arylamide derivative, induces cell apoptosis and displays synergistic anti-cancer activity with etoposide in human lung adenocarcinoma in vitro and in vivo | Chueh-Heng Wu; 吳珏衡 | 藥理學研究所 |
2013 | 新穎HDAC抑制劑-MPT0G028在人類大腸癌細胞之抗癌機轉探討 Anticancer activity of the novel histone deacetylase inhibitor, MPT0G028, in human colorectal cancer cells in vitro and in vivo | Chia-Hua Lee; 李嘉華 | 藥理學研究所 |